一项在糖尿病领域实现精准医疗的全球倡议。
A global initiative to deliver precision health in diabetes.
作者信息
Cefalu W T, Franks P W, Rosenblum N D, Zaghloul N A, Florez J C, Giorgino F, Ji L, Ma R C W, Mathieu C, Misra S, Ramirez A H, Roden M, Scherer P E, Sheu W H-H, Stehouwer C D A, Woo M, Pragnell M, Anand S S, Carnethon M, Chambers J C, Dennis J M, Gloyn A L, Herder C, Holt R I G, Manuel D G, Redondo M J, Tandon N, Tsang J S, Udler M S, Rich S S
机构信息
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Department of Clinical Sciences, Helsingborg Hospital, Lund University, Helsingborg, Sweden.
出版信息
Nat Med. 2024 Jul;30(7):1819-1822. doi: 10.1038/s41591-024-03032-4.
Abstract
A recent workshop brought together global leaders in diabetes to assess existing approaches to disease heterogeneity and to identify research gaps, with a goal of achieving precision diabetology for all patients globally.
摘要
最近举办的一次研讨会汇聚了全球糖尿病领域的领军人物，以评估针对疾病异质性的现有方法，并找出研究差距，目标是在全球范围内为所有患者实现精准糖尿病学。
相似文献
1
A global initiative to deliver precision health in diabetes.一项在糖尿病领域实现精准医疗的全球倡议。
Nat Med. 2024 Jul;30(7):1819-1822. doi: 10.1038/s41591-024-03032-4.
2
A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine.应对糖尿病异质性并推进精准医学的研究路线图。
J Clin Endocrinol Metab. 2025 Feb 18;110(3):601-610. doi: 10.1210/clinem/dgae844.
3
NIH Precision Medicine Initiative: Implications for Diabetes Research.美国国立卫生研究院精准医学计划：对糖尿病研究的启示
Diabetes Care. 2016 Jul;39(7):1080-4. doi: 10.2337/dc16-0541.
4
Unraveling diabetes complexity through natural products, miRNAs modulation, and future paradigms in precision medicine and global health.通过天然产物、miRNAs 调节以及精准医学和全球健康的未来范式来揭示糖尿病的复杂性。
Clin Nutr ESPEN. 2024 Oct;63:283-293. doi: 10.1016/j.clnesp.2024.06.043. Epub 2024 Jul 1.
5
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases.糖尿病的异质性：β细胞、表型与精准医学：加拿大卫生研究院营养、代谢与糖尿病研究所和美国国立卫生研究院国立糖尿病、消化和肾脏疾病研究所国际研讨会论文集
Can J Diabetes. 2021 Dec;45(8):697-713. doi: 10.1016/j.jcjd.2021.09.126. Epub 2021 Nov 15.
6
Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).精准医学与糖尿病：美国糖尿病协会（ADA）与欧洲糖尿病研究协会（EASD）的共识报告。
Diabetes Care. 2020 Jul;43(7):1617-1635. doi: 10.2337/dci20-0022.
7
Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).糖尿病精准医学：美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的共识报告。
Diabetologia. 2020 Sep;63(9):1671-1693. doi: 10.1007/s00125-020-05181-w.
8
Editorial: Rethinking the definition of diabetes for precision medicine.社论：为精准医学重新思考糖尿病的定义
Mol Endocrinol. 2015 Mar;29(3):335-7. doi: 10.1210/me.2015-1037.
9
Health Care Providers Can Deliver Personalized Precision Diabetes Care and Adopt GRI If It is Incorporated into a Centralized Platform.
J Diabetes Sci Technol. 2024 Sep;18(5):1249-1250. doi: 10.1177/19322968241257005. Epub 2024 Jun 5.
10
Precision diabetes: a realistic outlook on a promising approach.精准糖尿病：对一种前景广阔的方法的现实展望。
Diabetologia. 2017 May;60(5):766-768. doi: 10.1007/s00125-017-4244-0.
引用本文的文献
1
Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.糖尿病研究与照护中的全球挑战：何去何从？欧洲糖尿病研究协会全球委员会的评估
Diabetologia. 2025 Sep 10. doi: 10.1007/s00125-025-06504-5.
2
AI-Powered Diabetes Precision Health: From Data to Action.人工智能驱动的糖尿病精准健康：从数据到行动。
NEJM AI. 2025 Sep;2(9). doi: 10.1056/AIp2500475. Epub 2025 Aug 28.
3
Kidney Disease: Improving Global Outcomes Summit Recommendations on Implementation of Diabetes Management in CKD: From Primary to Data-Driven Collaborative Care.《肾脏病：改善全球预后》慢性肾脏病糖尿病管理实施峰会建议：从初级护理到数据驱动的协作护理
Kidney Int Rep. 2025 Jun 18;10(8):2551-2565. doi: 10.1016/j.ekir.2025.06.010. eCollection 2025 Aug.
4
Diabetes prevention and treatment: a global perspective.糖尿病的预防与治疗：全球视角
Diabetologia. 2025 Aug 12. doi: 10.1007/s00125-025-06511-6.
5
Single cell sequencing and spatial multiomics of diabetic kidney segmentation insights zonation-specific therapeutic metabolic pathways.糖尿病肾脏分割的单细胞测序和空间多组学揭示了特定区域的治疗性代谢途径。
Cell Insight. 2025 May 13;4(3):100252. doi: 10.1016/j.cellin.2025.100252. eCollection 2025 Jun.
6
A simplified protocol based on a standardized meal-stimulated beta-cell response to stratify people living with non-insulin-treated type 2 diabetes.一种基于标准化餐食刺激的β细胞反应的简化方案，用于对非胰岛素治疗的2型糖尿病患者进行分层。
Diabetes Obes Metab. 2025 Sep;27(9):5337-5341. doi: 10.1111/dom.16528. Epub 2025 Jun 11.
7
Diabetes and women's health.糖尿病与女性健康。
J Diabetes Investig. 2025 Jul;16(7):1173-1190. doi: 10.1111/jdi.70095. Epub 2025 Jun 10.
8
Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative.缩小1型糖尿病领域愿景与胜利之间的差距：美国国立糖尿病、消化和肾脏疾病研究所人类胰岛研究网络（HIRN）倡议
Diabetes. 2025 Jul 1;74(7):1057-1067. doi: 10.2337/db25-0097.
9
Nuclear regulatory disturbances precede and predict the development of Type-2 diabetes in Asian populations.核调节紊乱先于并预示亚洲人群2型糖尿病的发生。
medRxiv. 2025 Feb 14:2025.02.14.25322264. doi: 10.1101/2025.02.14.25322264.
10
The potential of precision diabetology for type 2 diabetes treatment-evidence from a meta-regression for all-cause mortality from large cardiovascular outcome trials.精准糖尿病学在2型糖尿病治疗中的潜力——来自大型心血管结局试验全因死亡率Meta回归分析的证据
Acta Diabetol. 2024 Dec 12. doi: 10.1007/s00592-024-02425-8.
本文引用的文献
1
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.关于精准糖尿病医学临床转化的差距与机遇的第二份国际共识报告
Nat Med. 2023 Oct;29(10):2438-2457. doi: 10.1038/s41591-023-02502-5. Epub 2023 Oct 5.
2
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment.一种新型糖尿病分类：从发病机制到治疗的精准糖尿病学。
Diabetologia. 2022 Nov;65(11):1770-1781. doi: 10.1007/s00125-021-05625-x. Epub 2022 Jan 4.
3
Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).糖尿病精准医学：美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的共识报告。
Diabetologia. 2020 Sep;63(9):1671-1693. doi: 10.1007/s00125-020-05181-w.
4
Precision medicine in type 2 diabetes.2 型糖尿病的精准医学。
J Intern Med. 2019 Jan;285(1):40-48. doi: 10.1111/joim.12859. Epub 2018 Dec 7.
Zotero 插件